The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Dechert LLP

CIRCA CENTRE, 2929 ARCH STREET, PHILADELPHIA, PA 19104-2808, USA
Tel:
Work +1 215 994 4000
Fax:
Fax +1 215 994 2222
Email:
Web:
www.dechert.com

James A Lebovitz

Tel:
Work +1 215 994 2510
Email:
Dechert LLP

Work Department

Corporate

Career

James A. Lebovitz represents clients in securities transactions, mergers and acquisitions, strategic alliances and general corporate matters. He has extensive experience advising public and privately-held corporations in the life sciences, healthcare, financial and business services sectors, business development companies (BDCs) and other specialty finance companies, and investment banks in corporate transactions and financings.

Education

Yale College, B.A., 1979, Editor-in-chief of the Yale Daily News; University of Virginia School of Law, J.D., 1982, Notes editor of The Virginia Journal of International Law; University of Cambridge, LL.M., 1983


United States: Finance

Capital markets: debt

Within: Capital markets: debt

Acting primarily for issuers, Dechert LLP is noted as ‘a leader in advising business development companies’, and is also well known in the life sciences sector. Recent highlights included James Lebovitz, who splits his time between Philadelphia and New York, advising a business development company on a $500m senior notes offering. In a high-profile multi-jurisdictional deal, Philadelphia partners William Lawlor and Ian Hartman advised Crown Holdings on two private placements of notes worth €335m and €500m respectively, which were issued by its French subsidiary. The team also advised Crown on a $875m private placement of notes issued by US subsidiaries. Boston-based Thomas Friedmann and New-York based David Rosenthal co-chair the corporate finance and capital markets practice.

[back to top]

Capital markets: equity offerings

Within: Capital markets: equity offerings

‘Collaborative, involved, professional and prompt’, Dechert LLP attracts praise for ‘seeking to understand the client’s business to provide a value-add service’. The group, which acts for corporate issuers and investment banks, is particularly prominent in advising business development companies and life sciences clients on equity deals. Among its recent highlights, Philadelphia-based private equity specialist Kenneth Young advised Corporate Capital Trust, a business development company, on its NYSE listing. New York-based group co-chair David Rosenthal (‘a trusted and valued advisor’) acted alongside Philadelphia’s Gregory Schernecke to advise Aquestive Therapeutics on its $67.5m IPO. Other key contacts include Boston-based department co-chair Thomas Friedmann, Philadelphia-based James Lebovitz and business development company specialist Harry Pangas, who recently joined in Washington DC from Eversheds Sutherland.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to